
No. of Pages: 138 | Report Code: TIPRE00003321 | Category: Life Sciences
No. of Pages: 138 | Report Code: TIPRE00003321 | Category: Life Sciences
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Europe Metagenomics Market – Key takeaways
PART 3. Europe Metagenomics market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Europe Metagenomics Market – By Product
3.2.2 Europe Metagenomics Market – By Application
3.2.3 Europe Metagenomics Market – By Country
3.3 PEST Analysis
PART 4. Europe Metagenomics market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Technological Advancements in Metagenomics
4.1.2 Growing Preference for Metagenomics Over Traditional Methods
4.1.3 Wide Range of Metagenomics Applications
4.2 Key Market Restraints
4.2.1 Highly Priced Metagenomics Technology
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis- Ushering In The Era Of Precision Medicine
4.4 Key Market Trends
4.4.1 Increasing Inclination towards Molecular-Based Approaches
4.5 Impact analysis
PART 5. Metagenomics market – Europe Analysis
5.1 Europe Metagenomics market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Illumina, Inc.
Qiagen
5.4 expert opinions
PART 6. Europe Metagenomics market Analysis – By Product
6.1 Overview
6.2 EUROPE metagenomics MARKET, BY product, 2018 & 2027 (%)
6.3 Europe Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Instruments & Software Market
6.4.1 Overview
6.4.2 Europe Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Consumables Market
6.5.1 Overview
6.5.2 Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. Europe Metagenomics market Analysis – By Application
7.1 Overview
7.2 EUROPE Metagenomics MARKET, BY application, 2018 & 2027 (%)
7.3 Europe Metagenomics market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.4 Clinical Diagnostic Market
7.4.1 Overview
7.4.2 Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Drug Discovery metagenomics Market
7.5.1 Overview
7.5.2 Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. Europe Metagenomics market Revenue and Forecasts to 2027
8.1 Overview
8.2 Europe Metagenomics Market Revenue And Forecasts to 2027, By Country (%)
8.3 UK Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.3.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 Germany Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.4.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.5 France Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.5.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.5.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. Metagenomics Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.3.1 Overview
9.4 Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
9.5 Product Launch
9.5.1 Recent Product Launch By Players In The Metagenomics Market
9.6 Product approval
9.6.1 Recent Product Approval By Players In The Metagenomics Market
9.7 Expansion & Others
9.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
9.8 Inorganic developments
9.8.1 Overview
9.9 inOrganic Growth Strategies in the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.10.1 Acquisitions By Players In The Metagenomics Market
9.11 Agreements
9.11.1 The Metagenomics Market By Agreements
9.12 Partnership & Collaboration
9.12.1 Partnership By Players In The Metagenomics Market
PART 10. Metagenomics Market–Key company profiles
10.1 Merck KGaA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Agilent Technologies, Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 QIAGEN
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Perkin Elmer, inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Illumina, Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Oxford Nanopore Technologies Ltd.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product & Services Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Pacific Bioscience of California, inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product & Services Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. Europe Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. Europe Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 3. UK Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 4. UK Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 5. Germany Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 6. Germany Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. France Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 8. France Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 9. Recent Product Launch in the Metagenomics Market
TABLE 10. Recent Product Approval and Enhancements in the Metagenomics Market
TABLE 11. the Metagenomics Market by Exansion & Others Strategies
TABLE 12. Acquisitions in the Metagenomics Market
TABLE 13. the Metagenomics Market by Agreements
TABLE 14. partnership in the Metagenomics Market
TABLE 15. Glossary of Terms, Metagenomics market
LIST OF FIGURES
FIGURE 1. GErmany Metagenomics market, Revenue (US$ Mn), By 2018 & 2027
FIGURE 2. Europe Metagenomics Market By product, Market Share (%), 2018
FIGURE 3. Europe Metagenomics Market By application, Market Share (%), 2018
FIGURE 4. Metagenomics market Segmentation
FIGURE 5. Europe PEST Analysis
FIGURE 6. Metagenomics market impact analysis of drivers & Restraints
FIGURE 7. Europe Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027
FIGURE 8. Europe metagenomics market By Product, 2018 & 2027 (%)
FIGURE 9. Europe Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 10. Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 11. Europe Metagenomics market By application, 2018 & 2027 (%)
FIGURE 12. Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. Europe Metagenomics Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 16. Europe metagenomics Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 17. UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Growth Strategies in the Metagenomics Market, 2015-2018
FIGURE 21. Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
FIGURE 22. Inorganic developments in the Metagenomics Market, 2015-2018
The List of Companies - Europe Metagenomics Market